Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Liraglutide | Liraglutide may increase the hypoglycemic activities of Insulin peglispro. |
| Metreleptin | Metreleptin may increase the hypoglycemic activities of Insulin peglispro. |
| Pegvisomant | The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Insulin peglispro. |
| Pioglitazone | The risk or severity of adverse effects can be increased when Pioglitazone is combined with Insulin peglispro. |
| Pramlintide | Pramlintide may increase the hypoglycemic activities of Insulin peglispro. |
| Rosiglitazone | The risk or severity of congestive heart failure can be increased when Insulin peglispro is combined with Rosiglitazone. |
| Lipoic acid | The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Insulin peglispro. |
| Edetic acid | Edetic acid may increase the hypoglycemic activities of Insulin peglispro. |
| Peginterferon alfa-2a | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Peginterferon alfa-2a. |
| Pegfilgrastim | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Pegfilgrastim. |
| Peginterferon alfa-2b | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Peginterferon alfa-2b. |
| Pegaspargase | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Pegaspargase. |
| Pegademase | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Pegademase. |
| Propylene glycol | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Propylene glycol. |
| Heptaethylene glycol | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Heptaethylene glycol. |
| Pegaptanib | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Pegaptanib. |
| Egaptivon pegol | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Egaptivon pegol. |
| PEG-uricase | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with PEG-uricase. |
| Peginterferon alfacon-1 | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Peginterferon alfacon-1. |
| GlycoPEG-GCSF | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with GlycoPEG-GCSF. |
| Pegnivacogin | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Pegnivacogin. |
| Pegpleranib | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Pegpleranib. |
| Pegsunercept | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Pegsunercept. |
| Polidocanol | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Polidocanol. |
| Peginesatide | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Peginesatide. |
| Certolizumab pegol | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Certolizumab pegol. |
| Methoxy polyethylene glycol-epoetin beta | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Methoxy polyethylene glycol-epoetin beta. |
| Peginterferon beta-1a | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Peginterferon beta-1a. |
| Pegloticase | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Pegloticase. |
| Polyethylene glycol | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Polyethylene glycol. |
| Antihemophilic factor (recombinant), PEGylated | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Antihemophilic factor (recombinant), PEGylated. |
| Eptacog alfa pegol (activated) | The therapeutic efficacy of Eptacog alfa pegol (activated) can be decreased when used in combination with Insulin peglispro. |
| Olaptesed Pegol | The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Insulin peglispro. |
| Abicipar Pegol | The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Insulin peglispro. |
| Lexaptepid pegol | The therapeutic efficacy of Lexaptepid pegol can be decreased when used in combination with Insulin peglispro. |
| Cepeginterferon alfa-2B | The therapeutic efficacy of Cepeginterferon alfa-2B can be decreased when used in combination with Insulin peglispro. |
| Pegvaliase | The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Insulin peglispro. |
| Pegamotecan | The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Insulin peglispro. |
| Lipegfilgrastim | The therapeutic efficacy of Lipegfilgrastim can be decreased when used in combination with Insulin peglispro. |
| Nonacog beta pegol | The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Insulin peglispro. |
| Damoctocog alfa pegol | The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Insulin peglispro. |
| Elapegademase | The therapeutic efficacy of Elapegademase can be decreased when used in combination with Insulin peglispro. |
| Esmolol | Esmolol may increase the hypoglycemic activities of Insulin peglispro. |
| Landiolol | Landiolol may increase the hypoglycemic activities of Insulin peglispro. |
| Moxifloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Moxifloxacin. |
| Grepafloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Grepafloxacin. |
| Enoxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Enoxacin. |
| Pefloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Pefloxacin. |
| Ciprofloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Ciprofloxacin. |
| Trovafloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Trovafloxacin. |
| Nalidixic acid | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Nalidixic acid. |
| Rosoxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Rosoxacin. |
| Cinoxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Cinoxacin. |
| Lomefloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Lomefloxacin. |
| Gatifloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Gatifloxacin. |
| Norfloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Norfloxacin. |
| Levofloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Levofloxacin. |
| Gemifloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Gemifloxacin. |
| Ofloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Ofloxacin. |
| Sparfloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Sparfloxacin. |
| Temafloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Temafloxacin. |
| Fleroxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Fleroxacin. |
| Technetium Tc-99m ciprofloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Technetium Tc-99m ciprofloxacin. |
| Garenoxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Garenoxacin. |
| Nemonoxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Nemonoxacin. |
| Flumequine | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Flumequine. |
| Enrofloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Enrofloxacin. |
| Orbifloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Orbifloxacin. |
| Sarafloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Sarafloxacin. |
| Difloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Difloxacin. |
| Pazufloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Pazufloxacin. |
| Prulifloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Prulifloxacin. |
| Delafloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Delafloxacin. |
| Sitafloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Sitafloxacin. |
| Oxolinic acid | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Oxolinic acid. |
| Rufloxacin | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Rufloxacin. |
| Pipemidic acid | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Pipemidic acid. |
| Methyclothiazide | The risk or severity of hypoglycemia can be increased when Methyclothiazide is combined with Insulin peglispro. |
| Chlorthalidone | The risk or severity of hypoglycemia can be increased when Chlorthalidone is combined with Insulin peglispro. |
| Bendroflumethiazide | The risk or severity of hypoglycemia can be increased when Bendroflumethiazide is combined with Insulin peglispro. |
| Metolazone | The risk or severity of hypoglycemia can be increased when Metolazone is combined with Insulin peglispro. |
| Benzthiazide | The risk or severity of hypoglycemia can be increased when Benzthiazide is combined with Insulin peglispro. |
| Hydroflumethiazide | The risk or severity of hypoglycemia can be increased when Hydroflumethiazide is combined with Insulin peglispro. |
| Indapamide | The risk or severity of hypoglycemia can be increased when Indapamide is combined with Insulin peglispro. |
| Chlorothiazide | The risk or severity of hypoglycemia can be increased when Chlorothiazide is combined with Insulin peglispro. |
| Hydrochlorothiazide | The risk or severity of hypoglycemia can be increased when Hydrochlorothiazide is combined with Insulin peglispro. |
| Trichlormethiazide | The risk or severity of hypoglycemia can be increased when Trichlormethiazide is combined with Insulin peglispro. |
| Polythiazide | The risk or severity of hypoglycemia can be increased when Polythiazide is combined with Insulin peglispro. |
| Quinethazone | The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin peglispro. |
| Cyclopenthiazide | The risk or severity of hypoglycemia can be increased when Cyclopenthiazide is combined with Insulin peglispro. |
| Epitizide | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Epitizide. |
| Protriptyline | Protriptyline may decrease the hypoglycemic activities of Insulin peglispro. |
| Amoxapine | Amoxapine may decrease the hypoglycemic activities of Insulin peglispro. |
| Trimipramine | Trimipramine may decrease the hypoglycemic activities of Insulin peglispro. |
| Amineptine | Amineptine may decrease the hypoglycemic activities of Insulin peglispro. |
| Dimetacrine | Dimetacrine may decrease the hypoglycemic activities of Insulin peglispro. |
| Butriptyline | Butriptyline may decrease the hypoglycemic activities of Insulin peglispro. |
| Dosulepin | Dosulepin may decrease the hypoglycemic activities of Insulin peglispro. |
| Tianeptine | Tianeptine may decrease the hypoglycemic activities of Insulin peglispro. |
| Oxaprotiline | Oxaprotiline may decrease the hypoglycemic activities of Insulin peglispro. |